Skip to main content

and
  1. No Access

    Article

    Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study

    This study was performed to evaluate circulating tumor DNA (ctDNA) kinetics during postoperative radiotherapy (PORT) in patients with residual triple-negative breast cancer (TNBC) at surgery following neoadjuv...

    Haeyoung Kim, Yeon Jeong Kim, Donghyun Park in Breast Cancer Research and Treatment (2021)

  2. Article

    Open Access

    Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas

    The 2016 World Health Organization (WHO) classification introduced nodal lymphomas of T follicular helper (Tfh) cell origin, such as angioimmunoblastic T-cell lymphoma (AITL), follicular peripheral T-cell lymp...

    Sang Eun Yoon, Junhun Cho, Yeon Jeong Kim in Experimental Hematology & Oncology (2021)

  3. No Access

    Article

    Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas

    Cell-free DNA (cfDNA) can be released from tumor cells during proliferation and apoptosis; thus, a fraction of the cfDNA in patients with cancer is tumor-derived. However, the prognostic value of cfDNA in aggr...

    Joon Young Hur, Yeon Jeong Kim, Sang Eun Yoon, Dae-Soon Son in Annals of Hematology (2020)

  4. No Access

    Article

    Risk stratification of triple-negative breast cancer with core gene signatures associated with chemoresponse and prognosis

    Neoadjuvant chemotherapy studies have consistently reported a strong correlation between pathologic response and long-term outcome in triple-negative breast cancer (TNBC). We aimed to define minimal gene signa...

    Eun-Kyu Kim, Ae Kyung Park, Eunyoung Ko in Breast Cancer Research and Treatment (2019)

  5. Article

    Open Access

    Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma

    The immunogenomic changes triggered by concurrent chemoradiation therapy (CCRT), a standard neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (ESCC), are unknown. We aimed to analyz...

    Sehhoon Park, Je-Gun Joung, Yang Won Min in Journal for ImmunoTherapy of Cancer (2019)

  6. No Access

    Article

    Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer

    This study investigated the correlations between parameters of 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) scan and indices of genetic properties, heterogeneity index (HI), and tumor...

    Seung Hwan Moon, **ho Kim, Je-Gun Joung in European Journal of Nuclear Medicine and M… (2019)

  7. Article

    Open Access

    Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification

    Patient-derived xenograft (PDX) models are important tools in precision medicine and for the development of targeted therapies to treat cancer patients. This study aimed to evaluate our precision medicine stra...

    Doo-Yi Oh, Kyungsoo Jung, Ji-Young Song, Seokhwi Kim, Sang Shin in BMC Cancer (2017)

  8. Article

    Open Access

    Predicting multi-class responses to preoperative chemoradiotherapy in rectal cancer patients

    Preoperative chemoradiotherapy (CRT) has become a widely used treatment for improving local control of disease and increasing survival rates of rectal cancer patients. We aimed to identify a set of genes that ...

    Jungsoo Gim, Yong Beom Cho, Hye Kyung Hong, Hee Cheol Kim in Radiation Oncology (2016)

  9. Article

    Open Access

    Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab

    Inhibition of the activated epidermal growth factor receptor (EGFR) with either enzymatic kinase inhibitors or anti-EGFR antibodies such as cetuximab, is an effective modality of treatment for multiple human c...

    Jeonghee Cho, Adam J Bass, Michael S Lawrence, Kristian Cibulskis in Molecular Cancer (2014)

  10. Article

    Open Access

    A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study

    Although approximately 25 common genetic susceptibility loci have been identified to be independently associated with breast cancer risk through genome-wide association studies (GWAS), the genetic risk variant...

    Hyung-cheol Kim, Ji-Young Lee, Hyuna Sung, Ji-Yeob Choi in Breast Cancer Research (2012)

  11. No Access

    Article

    Identification of radiation-specific responses from gene expression profile

    The responses to ionizing radiation (IR) in tumors are dependent on cellular context. We investigated radiation-related expression patterns in Jurkat T cells with nonsense mutation in p53 using cDNA microarray...

    Woong-Yang Park, Chang-Il Hwang, Chang-Nim Im, Min-Ji Kang, Jang-Hee Woo in Oncogene (2002)